Effects of Blood Transfusion on the Risk of Hepatitis C Infection in Hemodialysis Patients: A Meta-Analysis

Yuli Astuti, Yulia Lanti Retno Dewi, Bhisma Murti

Abstract

Background: It is estimated that 2% of the world's population (about 123 million people) was infected with hepatitis C. Blood transfusion is one of the therapies, but this therapy is at risk of being a transmission me­dium for hepatitis B infection. Hemo­dia­ly­sis patients are in the group at risk of having hepatitis C infection. Patients with a history of blood transfusions in this group increase the incidence of hepatitis C infec­tion. This study aimed to determine the estimated effect of blood transfusions on hepatitis C infec­tion in hemodialysis pa­tients with a meta-analysis.

Subjects and Method: Meta-analysis was con­duc­ted by searching for articles from databases such as Google Scholar, Pub­Med, Springer Link, and Research Gate. The keywords were "blood tran­s­fu­sion" OR "risk factor" AND "hepatitis C in­fec­tion" OR "TTI" OR "HBV" AND "patient hemo­dialysis" OR "Patient renal failure". The inclusion criteria were full-text articles, from 2000-2020, with a cross-sectional stu­dy design. The articles were analyzed using RevMan 5.3.

Results: There were 9 articles analyzed. The results showed that blood transfusions in­creased the incidence of hepatitis C infec­tion in hemo­dia­ly­sis patients (aOR= 1.55; 95% CI= 1.19 to 2.03; p= 0.001) and I2= 90%. Based on the meta-ana­lysis result, there was no publication bias.

Conclusion: Blood transfusion affects he­mo­­dia­lys­is patients with hepatitis C in­fec­tion.

Keywords: blood transfusion, hepatitis C infec­tion, hemodialysis patients

Correspondence: Yuli Astuti. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Sura­kar­ta 57126, Central Java. Email: ­yuli­as­tu­ti­12­2­4­@gmail.com. Mobile: 0838­2­1­875621

Journal of Epidemiology and Public Health (2020), 05(03): 339-347
https://doi.org/10.26911/jepublichealth.2020.05.03.08.

 

Full Text:

PDF

References

Ahn E, Kang H (2018). Introduction to Sys-tematic Review and Meta-Analysis: A Health Care Perspective. Korean J Anesthesiol, 71(2), 1–38.


Amiri Z, Shakib A, Toorchi M (2005) . Sero-prevalence of hepatitis C and risk fac-tors in haemodialysis patients in Guilan, Islamic Republic of Iran. EMH-J, 11(3) , 372-376.


Caragea D, Mihailovici AR, Streba CT, Schenker M, Ungureanu B, Caragea IN, Popa R, Obleaga C, Vere CC (2018). Hepatitis C infection in Hemodialysis Patients. Curr Health Sci J, 44(2): 107–112.


Centers for Disease Control (2012). Hepatitis B—2012. Yellow Book. Retrieved from wwwnc.cdc.gov/travel/yellowbook/2-014/chapter-3-infectious-diseases-related-to-travel/hepatitis-b.


Contantio NS, Feraz M, Martin CT, Kray-chete AC, Bitencourt PL, Nascimento MM (2018). Hepatitis C in Hemodialysis Unit: Diagnosis and Theraupetic Approach. J Braz Nefrol, 11(4):539-549.


Engle R, Bukh J, Alter H, Emerson S, Trenbeath, Nguyen, Purcell RH. (2014). Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors. Transfusion J, 54(11), 2833–2841.


Han R, Zhou J, Francois C, Thoumi M (2019). Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a sys-tematic review update. BMC Infect Dis, 19(1), 1-14.


Lopez L, Patricia L, Arago A, Rodiguez I, Jorge, LIma E, Insagaray J, Bentancor N (2005). Risk factor for hepatitis B and C in Multi-tranfused patient in Urugay. Journal of Clin Virol, 34 (2), S69-74.


La TG, Saulle R (2016). Risk factors from hepatitis B infection among blood donors: A systematic review. Asian Pac J Trop Biomed, 6(4), 344–349.


Morozov VA, Lagaye S (2018). Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol, 27;10(2): -186-212


Murti B (2016). Prinsip dan Metode Riset Epidemiologi. Colomadu, Karanganyar. Bintang Fajar Offset.


Oliveira AB, Piementa C, Rojas M, Chagaz M, Crespo M, Cresente B, Lemos R (2010). Likely transmission of hepatitis C virus through sharing of cutting and perfo-rating instruments in blood donors in the State of Pará, Northern Brazil. SciELO, 26(4):837-844.


Vadakedath S, Kandi V. 2017. Dyalisis: A Review of the Mechanisme Underlying Complications in the Management of Chronic Renal Failure. Cureus 9(8): 1603


World Health Organization (2012). Guidlines on Assess Donor Suitability for Blood Donation.


WHO (2020a). What is Hepatitis? Retrieved from https://www.who.int/news-room/qadetail/what-is-hepatitis. on June 10, 2020.


WHO (2020b). Clinical Transfusion Practice Guidelines for Medical Interns. Retrieved from https:www.who.int/bloodsa-fety/transfusion_services/Clinical-TransfusionPracticeGuidelinesforMedi-calInternsBangladesh.pdf


Yelima JD, Ufelle, Milgwe, Oyeleke, Denue, Chickwendu (2019). Complications of blood transfusion and management: Definitions and History Of Blood group systems. Eajournals Vol 7: (3): 25-34.

Refbacks

  • There are currently no refbacks.